Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
613.65
646.33
567.85
953.38
1,572.24
178.64
137.94
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
613.65
646.33
567.85
953.38
1,572.24
178.64
137.94
Raw Material Cost
225.15
165.23
112.75
74.41
56.38
35.86
26.41
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
78.41
52.87
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.59
4.14
3.11
2.55
0.44
0.21
0.20
Selling and Distribution Expenses
265.84
255.80
187.55
134.10
144.49
82.16
54.18
Other Expenses
7.30
6.96
5.04
3.36
2.43
-5.66
-3.23
Total Expenditure (Excl Depreciation)
568.58
494.76
353.80
244.63
225.58
140.01
101.35
Operating Profit (PBDIT) excl Other Income
45.099999999999994
151.6
214.1
708.8
1346.6999999999998
38.6
36.6
Other Income
111.94
145.83
156.62
117.44
-32.97
1.96
1.20
Operating Profit (PBDIT)
241.74
359.03
403.81
849.82
1,320.08
49.05
42.54
Interest
4.59
4.14
3.11
2.55
0.44
0.21
0.20
Exceptional Items
4.88
10.98
-14.38
34.14
6.40
0.26
0.05
Gross Profit (PBDT)
388.50
481.10
455.10
878.96
1,515.86
142.78
111.53
Depreciation
100.70
77.92
43.81
35.96
12.94
9.83
6.62
Profit Before Tax
141.33
287.95
342.51
845.45
1,313.11
39.27
35.77
Tax
19.41
27.82
39.55
125.44
185.50
2.86
-0.59
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
121.93
260.13
302.96
720.01
1,127.61
36.41
36.35
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
121.93
260.13
302.96
720.01
1,127.61
36.41
36.35
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
121.93
260.13
302.96
720.01
1,127.61
36.41
36.35
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
5,772.91
6,366.98
6,369.10
6,752.31
1,298.64
149.81
79.01
Earnings per share (EPS)
0.95
2.01
2.34
5.57
8.73
0.28
0.28
Diluted Earnings per share
0.95
2.01
2.34
5.57
8.73
0.28
0.28
Operating Profit Margin (Excl OI)
4.74%
20.93%
35.82%
73.05%
85.24%
20.85%
25.17%
Gross Profit Margin
39.44%
56.61%
68.03%
92.45%
84.34%
27.49%
30.73%
PAT Margin
19.87%
40.25%
53.35%
75.52%
71.72%
20.38%
26.35%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is -5.04% vs 13.81% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -53.13% vs -14.16% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is -39.12% vs -13.75% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 12.20% vs 32.26% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of Sino Biological Inc. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
613.65
0
613.65
Other Operating Income
0.00
0.00
0.00
Total Operating income
613.65
0
613.65
Raw Material Cost
225.15
0
225.15
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.59
0
4.59
Selling and Distribution Expenses
265.84
0
265.84
Other Expenses
7.30
0.00
7.30
Total Expenditure (Excl Depreciation)
568.58
0
568.58
Operating Profit (PBDIT) excl Other Income
45.07
0.00
45.07
Other Income
111.94
0
111.94
Operating Profit (PBDIT)
241.74
0
241.74
Interest
4.59
0
4.59
Exceptional Items
4.88
0
4.88
Gross Profit (PBDT)
388.50
0
388.50
Depreciation
100.70
0
100.70
Profit Before Tax
141.33
0
141.33
Tax
19.41
0
19.41
Provisions and contingencies
0
0
0.00
Profit After Tax
121.93
0
121.93
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
121.93
0
121.93
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
121.93
0
121.93
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
5,772.91
0
5,772.91
Earnings per share (EPS)
0.95
0
0.95
Diluted Earnings per share
0.95
0
0.95
Operating Profit Margin (Excl OI)
4.74%
0%
0.00
4.74%
Gross Profit Margin
39.44%
0%
0.00
39.44%
PAT Margin
19.87%
0%
0.00
19.87%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 61.37 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -5.04% vs 13.81% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 12.19 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -53.13% vs -14.16% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.98 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -39.12% vs -13.75% in Dec 2023
Annual - Interest
Interest 0.46 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 12.20% vs 32.26% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.74%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023






